Birdwatch Archive

Birdwatch Note Rating

2024-10-23 11:56:47 UTC - HELPFUL

Rated by Participant: 96BBF204BFEB1F791781CE48A972D4B75B44E57E78C4FAF14059BB1D43B8D39A
Participant Details

Original Note:

Misleading headline. The drugs will not be banned, they will simply not be funded/available to NHS patients due to prohibitive cost. The drugs have been declared safe and will be available to private patients or as part of clinical trials, as per the linked article. https://www.telegraph.co.uk/news/2024/10/22/donanemab-alzheimers-effective-wonder-drug-nhs-ban/

All Note Details

Original Tweet

All Information

  • noteId - 1849046046686449749
  • participantId -
  • raterParticipantId - 96BBF204BFEB1F791781CE48A972D4B75B44E57E78C4FAF14059BB1D43B8D39A
  • createdAtMillis - 1729684607747
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 184904604668644974996BBF204BFEB1F791781CE48A972D4B75B44E57E78C4FAF14059BB1D43B8D39A